This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Hansen Medical 3Q Loss Narrows On Lower Costs

MOUNTAIN VIEW, Calif. (AP) ¿ Hansen Medical Inc., which makes medical robotic technology used with catheters, said Monday its third-quarter loss narrowed as the company lowered costs.

Hansen said it lost $11.9 million, or 32 cents per share, compared with a loss of $12.9 million, or 51 cents per share a year earlier. Per-share results in the most recent quarter were based on about 12 million additional shares of common stock.

Revenue fell sharply to $4.6 million from $9.6 million.

Analysts polled by Thomson Reuters had forecast a loss of 33 cents per share and revenue of $5.8 million, on average.

"The current economic environment continues to create challenges in expanding the sale of capital equipment in the early stages of commercialization like our Sensei Robotic Catheter System," said President and CEO Dr. Frederic Moll, in a statement.

The company said it recognized revenue on the sale of five Sensei Robotic Systems, and shipped five others. Hansen also sold 497 Artisan Control Catheters in the third quarter.

Operating expenses fell 19 percent to $13 million from $16.2 million.

Shares of Hansen rose 9 cents, or 3.2 percent, to $2.82 in after-hours trading after shedding 27 cents, or 9 percent, to close at $2.73 during the regular trading session.
Copyright 2009 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
HNSN $4.22 -0.47%
AAPL $112.03 2.30%
FB $93.24 0.83%
GOOG $643.48 0.68%
TSLA $220.69 -2.66%


Chart of I:DJI
DOW 17,084.49 +33.74 0.20%
S&P 500 2,013.43 +15.91 0.80%
NASDAQ 4,830.47 +19.6820 0.41%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs